Business / Finance

RSS

InMed, University of Debrecen partner to develop novel therapies to treat ocular allergies

InMed Pharmaceuticals Inc. announces it has formed an exclusive strategic collaboration with the University of Debrecen, Hungary, to develop novel phytocannabinoid-based therapies to treat ocular allergic symptoms.

10 Mar 2015

Impax Laboratories acquires Tower Holdings and Lineage Therapeutics

Impax Laboratories, Inc. today announced that it has completed its acquisition of Tower Holdings, Inc. (including operating subsidiaries CorePharma LLC and Amedra Pharmaceuticals LLC), and Lineage Therapeutics Inc. (together, the "Companies").

10 Mar 2015

VENITI closes $17 million in equity and debt financing

VENITI, Inc., a St. Louis, MO-based medical device company is pleased to announce that it has closed on an equity and debt financing totaling over $17 million. The equity portion, its Series C, was led by previous investors, Baird Capital and Tekla Healthcare and Tekla Life Science Investors, with strong internal participation.

10 Mar 2015

Advanced Cell Diagnostics' RNAscope technology supports biomarker-selected phase 2 clinical trial of Merrimack Pharmaceuticals' MM-121

Advanced Cell Diagnostics, Inc. (ACD) announced today that Merrimack Pharmaceuticals, Inc. is using ACD's RNAscope technology to select patients for its Phase 2 clinical trial of its product candidate MM-121.

From Advanced Cell Diagnostics 9 Mar 2015

BioTools unveils revolutionary family of portable raman microscopes

BioTool’s revolutionary new family of portable Raman microscopes bridges the gap between microscopy and spectroscopy, bringing microRaman out of the lab and into the world at large, opening new opportunities for doing the same analyses in different locations with the same instrumentation.

9 Mar 2015

IDT’s CRISPR/Cas9 online resource for all your genome editing needs

Integrated DNA Technologies (IDT) has pooled its expertise in genome editing into a free web resource dedicated to providing researchers a hub of information on the very latest in using the CRISPR/Cas9 system.

From Integrated DNA Technologies 9 Mar 2015

Particle Sciences to expand sterile manufacturing for complex products and particulates

Particle Sciences, Inc (PSI), the leading CDMO for micro and nano-particulates is expanding its sterile and aseptic manufacturing capacity generally and specifically for nano-milled drug products.

9 Mar 2015

G-treeBNT to receive $7.28 million to expand international development of RGN-259/GBT-201

RegeneRx Biopharmaceuticals, Inc. has been notified that its joint venture partner and licensee, G-treeBNT Co. Ltd., will receive $7.28 million USD to expand international development of its product candidate, RGN-259 (designated GBT-201).

9 Mar 2015

Greystone expands with acquisition of Autumn Health Care's skilled nursing facilities in Ohio

Greystone Healthcare Management Corp. continues to grow its network of healthcare facilities, home health agencies and hospice care services in Florida and Ohio with the acquisition from Autumn Health Care of its 10 skilled nursing facilities, with a total of 614 beds, in the central Ohio area.

9 Mar 2015

EMD Serono executes amendment agreement with Opexa for development of Tcelna (imilecleucel-T)

EMD Serono, the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, announced today the execution of an amendment to its agreement with Opexa Therapeutics, Inc. for the development and commercialization of its investigational compound Tcelna (imilecleucel-T).

9 Mar 2015

Carter Validus Mission Critical REIT II buys Heartland Rehabilitation Hospital property from Medistar

Medistar Corporation announced that it has sold the Heartland Rehabilitation Hospital property to Carter Validus Mission Critical REIT II, Inc. on February 17th 2015. The rehabilitation hospital is located in Overland Park, Kansas.

5 Mar 2015

Nova Medical Centers announces acquisition of Industrial Medicine

Occupational medicine company, Nova Medical Centers, is excited to announce the acquisition of Industrial Medicine, P.C. in Savannah, GA.

5 Mar 2015

European launch of the Proxima miniature in-line blood gas analyser at ISICEM 2015

Sphere Medical, innovator in critical care monitoring and diagnostics equipment, will launch its ground-breaking in-line patient dedicated arterial blood gas analyser in Germany, Netherlands and Belgium at ISICEM 2015.

5 Mar 2015

Mallinckrodt enters into definitive agreement to acquire Ikaria

Mallinckrodt plc, a leading global specialty biopharmaceutical company, and Ikaria, Inc. a privately-held critical care company, announced today that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt will acquire Ikaria, Inc. from a Madison Dearborn-led investor group in a transaction valued at approximately $2.3 billion.

5 Mar 2015

ANI acquires approved ANDA for Flecainide Acetate tablets USP

ANI Pharmaceuticals, Inc. today announced that it has acquired the approved abbreviated new drug application ("ANDA") for Flecainide Acetate tablets USP 50mg, 100mg and 150mg, previously marketed by Teva Pharmaceuticals.

5 Mar 2015

Babies treated for CMV infection for six months have better developmental outcomes

Babies treated for symptomatic cytomegalovirus (CMV) infection for six months, instead of the standard six weeks, have better hearing and developmental outcomes, according to a new study from the University of Alabama at Birmingham.

5 Mar 2015

Surgical science wins ACG minnesota BOLD award

Surgical Science, leading developer of virtual reality surgical simulation training systems, was the recipient of the 2015 Small Corporate BOLD Award from the Association for Corporate Growth (ACG) Minnesota.

4 Mar 2015

IMRIS announces net loss of $6.8 million for fourth quarter 2014

IMRIS Inc. today reported financial results for the fourth quarter and full year ended December 31, 2014. All figures are reported in U.S. dollars. The Company's net loss in the 2014 fourth quarter was $6.8 million, or $0.13 per diluted share, on net revenues of $9.6 million.

4 Mar 2015

Mayo Clinic, Gentag partner to develop wearable biosensors for treating obesity, diabetes

Mayo Clinic and Gentag, Inc. have reached an agreement to develop the next generation of wearable biosensors designed to fight obesity and diabetes.

4 Mar 2015

PINN partners with Clinicient to strengthen clinical and business decisions

Clinicient Inc., a leader in outpatient rehabilitation business solutions, announced today that People's Injury Network Northwest, a preeminent industrial rehabilitation physical and occupational therapy provider in Washington state, has selected Clinicient's PracticeInsight cloud-based EMR and billing solutions.

4 Mar 2015

Business / Finance

InMed, University of Debrecen partner to develop novel therapies to treat ocular allergies

Impax Laboratories acquires Tower Holdings and Lineage Therapeutics

VENITI closes $17 million in equity and debt financing

Advanced Cell Diagnostics' RNAscope technology supports biomarker-selected phase 2 clinical trial of Merrimack Pharmaceuticals' MM-121

BioTools unveils revolutionary family of portable raman microscopes

IDT’s CRISPR/Cas9 online resource for all your genome editing needs

Particle Sciences to expand sterile manufacturing for complex products and particulates

G-treeBNT to receive $7.28 million to expand international development of RGN-259/GBT-201

Greystone expands with acquisition of Autumn Health Care's skilled nursing facilities in Ohio

EMD Serono executes amendment agreement with Opexa for development of Tcelna (imilecleucel-T)

Carter Validus Mission Critical REIT II buys Heartland Rehabilitation Hospital property from Medistar

Nova Medical Centers announces acquisition of Industrial Medicine

European launch of the Proxima miniature in-line blood gas analyser at ISICEM 2015

Mallinckrodt enters into definitive agreement to acquire Ikaria

ANI acquires approved ANDA for Flecainide Acetate tablets USP

Babies treated for CMV infection for six months have better developmental outcomes

Surgical science wins ACG minnesota BOLD award

IMRIS announces net loss of $6.8 million for fourth quarter 2014

Mayo Clinic, Gentag partner to develop wearable biosensors for treating obesity, diabetes

PINN partners with Clinicient to strengthen clinical and business decisions

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Latest News